Regulatory and microbiological safety issues surrounding cell and tissue-engineering products.
Biotechnol Appl Biochem
; 40(Pt 1): 35-9, 2004 Aug.
Article
en En
| MEDLINE
| ID: mdl-15270705
ABSTRACT
Cell therapies and tissue-engineered products that contain living cells are potentially some of the most exciting of the novel therapeutic products currently under development. These products, however, present a number of important safety issues, particularly with respect to the transmission of human viruses. In addition, the short shelf life of these products precludes the normally extensive characterization performed on other biotherapeutic products. Careful examination of the risks and extensive testing of the raw materials have been used in place of product testing to ensure safety.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Vigilancia de Productos Comercializados
/
Medición de Riesgo
/
Transmisión de Enfermedad Infecciosa
/
Seguridad de Productos para el Consumidor
/
Ingeniería de Tejidos
/
Tratamiento Basado en Trasplante de Células y Tejidos
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Biotechnol Appl Biochem
Asunto de la revista:
BIOQUIMICA
/
BIOTECNOLOGIA
Año:
2004
Tipo del documento:
Article
País de afiliación:
Reino Unido